Background—Although heart failure (HF) is a syndrome with important differences in
response to therapy by left ventricular ejection fraction (LVEF), existing risk stratification …

BACKGROUND: Recent guidelines proposed a classification for heart failure (HF) on the
basis of left ventricular ejection fraction (LVEF), although it remains unclear whether the …

Background Several therapies are guideline‐recommended to reduce mortality in patients
with heart failure (HF) and reduced left ventricular ejection fraction, but the incremental …

Importance Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized
phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that …

Background—Evidence-based therapies for heart failure (HF) differ significantly according to
left ventricular ejection fraction (LVEF). However, few data are available on the phenotype …

Epidemiologic reports suggest that approximately 50% of patients who have signs or
symptoms of heart failure (HF) have preserved left ventricular ejection fraction (LVEF) …

Objectives: This study investigated adherence to drug therapy guidelines in heart failure
(HF) with reduced left-ventricular ejection fraction (LVEF) of< 40%(heart failure with reduced …

Aims Heart failure (HF) patients with a mid‐range ejection fraction (HFmrEF) are not well
characterized. Accordingly, we examined the epidemiology, pathophysiology and clinical …

Background: Guidelines strongly recommend patients with heart failure with reduced
ejection fraction (HFrEF) be treated with multiple medications proven to improve clinical …

Background—A treatment gap exists between heart failure (HF) guidelines and the clinical
care of patients. The Registry to Improve the Use of Evidence-Based Heart Failure …